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Abstract
Background: The purpose of this study was to examine the cardiovascular effects of two low-
levels of caffeine ingestion in non habitual caffeine users at various submaximal and maximal
exercise intensities.
Methods: Nine male subjects (19–25 yr; 83.3 ± 3.1 kg; 184 ± 2 cm), underwent three testing
sessions administered in a randomized and double-blind fashion. During each session, subjects were
provided 4 oz of water and a gelatin capsule containing a placebo, 1.5 mg/kg caffeine, or 3.0 mg/kg
caffeine. After thirty minutes of rest, a warm-up (30 Watts for 2 min) the pedal rate of 60 rpm was
maintained at a steady-state output of 60 watts for five minutes; increased to 120 watts for five
minutes and to 180 watts for five minutes. After a 2 min rest the workload was 180 watts for one
minute and increased by 30 watts every minute until exhaustion. Heart rate (HR) was measured
during the last 15-seconds of each minute of submaximal exercise. Systolic blood pressure (BP) was
measured at rest and during each of the three sub-maximal steady state power outputs. Minute
ventilation (VE), Tidal volume (VT), Breathing frequency (Bf), Rating of perceived exertion (RPE),
Respiratory exchange ratio (RER), and Oxygen consumption (VO2) were measured at rest and
during each minute of exercise.
Results: Caffeine at 1.5 and 3.0 mg/kg body weight significantly lowered (p < 0.05) HR during all
three submaximal exercise intensities compared to placebo (range – 4 to 7 bpm lower) but not at
rest or maximal exercise. BP was significantly higher (p < 0.05) at rest and after the 3 mg/kg caffeine
vs placebo (116 ± 13 vs 123 ± 10 mm Hg). Neither dose of caffeine had any effect on BP during
submaximal exercise. Caffeine had no effect on VE, VT, VO2, RPE, maximal power output or time
to exhaustion.
Conclusion: In non habitual caffeine users it appears that consuming a caffeine pill (1.5 & 3.0 mg/
kg) at a dose comparable to 1–3 cups of coffee lowers heart rate during submaximal exercise but
not at near maximal and maximal exercise. In addition, this caffeine dose also only appears to affect
systolic blood pressure at rest but not during cycling exercise.
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Introduction
Caffeine is the most widely used drug in the world and the
use of caffeine or caffeine containing beverages is
extremely common among all levels of athletes hoping to
gain an ergogenic benefit. Previous investigations have
shown that caffeine enhances short-term power, short-
term high-intensity time to exhaustion, resistance to
fatigue, as well as endurance performance [1,2]. Thus caf-
feine is generally regarded to have ergogenic properties
and its use is currently banned by the NCAA at dose which
elicits a urinary concentration of 15 ug/ml; a dose which
is far higher than needed to achieve performance benefits
[2]. Much of the exercise research with caffeine has inves-
tigated potential mechanisms mediating performance.
Enhanced fat oxidation leading to glycogen sparing has
historically been a popular theory for the improvement in
endurance performance however this mechanism might
be incomplete. The inhibition of adenosine receptors
including those in the central nervous system is now con-
sidered by some to be a more likely mediator of caffeine's
ergogenic properties [1-3]. Some have added to the debate
suggesting that the inhibition of adenosine receptors
including those in the central nervous system could be a
more likely mediator of caffeine's ergogenic properties [1-
3]. While not considered to have a role in performance
enhancement, caffeine's cardiovascular effects have also
generated much interest. Much of this research however,
has been conducted in resting subjects and has investi-
gated the potential negative health consequences from
caffeine-induced elevations in blood pressure [4].
Investigations reporting the effect of caffeine on heart rate
during exercise are equivocal, with some indicating
increases [5-9], decreases [10-12], and no effect [13-28];
while those reporting blood pressure have typically found
higher values [9,11,16,17,20,22,25]. Caffeine dose, exer-
cise intensity, and caffeine habituation are all factors
which differ among these studies. Despite the fact that the
data is inconclusive, statements still reflect the common
notion that caffeine increases heart rate during exercise
and this type of statement is often made without reference
to dose, intensity of activity, or habituation status.
Because the ergogenic effect of caffeine has been shown to
occur at a dose lower than what has been typically used in
research studies [2], many athletes are likely using caffeine
at more moderate doses (< 5 mg/kg). Therefore investiga-
tions of the various cardiovascular effects of caffeine at
these lower doses are important. In addition, during their
training bouts and in competition many athletes use heart
rate monitors as an indicator of their optimal pace, there-
fore the effect of caffeine on heart rate could be of great
importance to the athlete. Thus, the purpose of this study
was to measure the cardiovascular effects of two low-levels
of caffeine ingestion (in pill form) in non habitual caf-
feine users at various submaximal and maximal exercise
intensities.
Methods
Subjects
Nine male college subjects, age 19–25 yr, body weight
(83.3 ± 9.3 kg) and height (184 ± 6 cm), volunteered to
participate in the study. All subjects were normotensive,
indicated non-habitual caffeine use (via a questionnaire),
and were aerobically active at the time of the study
(VO2max: 49.7 ± 6.3 ml/kg/min). All subjects were healthy
at the time of the study without any history of cardiovas-
cular or lung disease and none of the subjects was a
smoker. The protocol was explained along with possible
risks and discomforts and informed consent was obtained
in writing from each subject before testing. All procedures
were approved by the Institutional Review Board for the
Protection of Human Subjects of the University of Wis-
consin-Stevens Point.
Protocol
Using a double-blind protocol each subject completed
three experimental trials in random order. Trials were con-
ducted at the same time of day and were separated by at
least 48 hours. Subjects were asked to refrain from heavy
exercise the day before each trial and to keep the time of
their last meal consistent between each trial. Upon report-
ing to the laboratory for each trial, subjects closed their
eyes and were given approximately 4 oz of water and a gel-
atin capsule containing either a placebo, 1.5 mg/kg caf-
feine (CAF1.5 – equivalent to about 1.2 cups of coffee
[2]), or 3.0 mg/kg caffeine (CAF3). The subjects then
rested quietly for the next 30 minutes. During this time,
subjects filled out a survey which listed caffeine-contain-
ing products, and indicated amounts (if any) of consump-
tion of these products in the previous 48 hours. Six
subjects indicated no caffeine product use and three oth-
ers reported use of ≤ 106 mg in the last 48 hours.
Each subject completed their three exercise trials on a
Monark (Model 828 E) bicycle ergometer. For each exer-
cise session, after a warm-up period (30 Watts for 2 min)
a pedal rate of 60 rpm was maintained for the remainder
of the test. For the first phase the workload was initially set
at a steady-state power output of 60 watts (~30% of
VO2max) for five minutes; the workload was then increased
to 120 watts (~46 of VO2max) for five minutes and then to
180 watts (~64% of VO2max) for five minutes. The second
phase of the exercise protocol started after a 2 min rest.
The subjects were quickly brought back up to 180 watts
for one minute again maintaining a pedal rate of 60 rpm.
The workload was then increased by 30 watts every
minute until exhaustion (with exhaustion being deter-
mined when the 60 rpm pedal rate was no longer able toJournal of the International Society of Sports Nutrition 2007, 4:11 http://www.jissn.com/content/4/1/11
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be maintained). The subjects then were then cooled down
to ensure safety of the trial.
Measurements
Heart rate (HR) was measured using a Polar heart rate
monitor (Polar Beat, Stamford, CT). Heart rates were
recorded during the last 15-seconds of each minute of
exercise with both the fourth and fifth minute measure-
ments during submaximal exercise used for comparisons.
Minute ventilation (VE), Tidal volume (VT), breathing fre-
quency (Bf), respiratory exchange ratio (RER), and oxygen
consumption (VO2) was measured using a Sensor Medics
Metabolic Cart (model Vmax Spectra) at rest and during
each minute of exercise. Systolic blood pressure (BP) was
measured by auscultation over the left brachial artery once
at rest and twice during each of the three sub-maximal
steady state power outputs with both measurements used
for comparison; BP was not measured during the second
phase including maximal exercise. Rating of perceived
exertion (RPE) using a Borg category scale (6–20) was
recorded in the last 30-seconds during each of the three
sub-maximal steady state power outputs and at maximal
exercise. The final workload achieved and the time at that
workload was recorded as an indication of potential per-
formance differences.
Statistics
All data are reported as mean ± SD. Data were analyzed
using a 2 × 2 (caffeine/placebo x rest/exercise) analysis of
variance ANOVA with repeated measures in which the
subjects served as their own control. Mauchly's Test of
Sphericity was used to determine if there was a violation.
To correct for any violation of the sphericity assumption
with the repeated factors, a Greenhouse-Geisser correction
was applied to the F-ratio. When the ANOVA yielded a sig-
nificant F-ratio, a post hoc pairwise comparison of the fac-
tor was completed. All analyses were performed with SPSS
for Windows version 13.0 statistical package (SPSS Inc,
Chicago, IL). Statistical significance for all tests was set at
p ≤ 0.05.
Results
The data for the metabolic variables after 30 minutes of
rest can be seen in Table 1. RER was significantly lower for
the 3 mg/kg caffeine dose vs the placebo trial (p < 0.05).
There were no differences in the resting mean VE, VO2, VT,
and Bf between the three trials.
The HR responses for rest, the three submaximal intensi-
ties and at maximal exercise can be seen in Figure 1. HR
tended to be lower at rest after administration of CAF3 vs
placebo, however this was not statistically significant (p =
0.08). However the HR for both the CAF1.5 and the CAF3
trials were significantly lower (p < 0.05) vs the placebo
trial for all three submaximal intensities (the range was 4
to 7 bpm lower). This lower heart rate effect was not
present during the higher intensities used for the incre-
mental test (data not shown) or at maximal exercise.
There were no differences between the CAF1.5 vs the
CAF3 trials during submaximal or maximal exercise.
The mean BP responses for rest and the three submaximal
intensities are displayed in Figure 2. Resting systolic BP
was significantly higher (p < 0.05) after the CAF3 dose vs
placebo trial (116 ± 13 mmHg vs 123 ± 10 mmHg). Nei-
ther dose of caffeine had any effect on BP during submax-
imal exercise.
The mean respiratory and metabolic values during sub-
maximal and maximal exercise are displayed in Table 2.
RER was not different between trials for the lowest exer-
cise intensity (30% of VO2max). RER with CAF3 added was
Heart rate at rest and during exercise Figure 1
Heart rate at rest and during exercise. Differences in 
heart rate between placebo and caffeine trials. Placebo, 1.5 
and 3.0 represent dose of caffeine in mg·kg body weight-1. 
Values are listed as mean ± SE. * = the mean difference com-
pared to placebo is significant (p < 0.05).
50.0
70.0
90.0
110.0
130.0
150.0
170.0
190.0
Rest 30% 45% 63%   Peak
exercise intensity (%VO2max)
H
e
a
r
t
 
R
a
t
e
 
(
b
e
a
t
s
/
m
i
n
)
placebo
1.5 mg/kg
3.0 mg/kg
*
 *
* *
* *
Table 1: Respiratory and Metabolic values at rest
Placebo 1.5 CAF 3.0 CAF
VE (L·min-1) 13.4 ± 3.1 13.3 ± 2.3 14.2 ± 3.0
Bf (breaths·min-1) 16.2 ± 4.6 14.6 ± 2.4 16.6 ± 3.9
VT (L·breath-1) 0.93 ± 0.26 0.99 ± 0.20 0.95 ± 0.18
VO2(ml·kg-1·min-1) 5.2 ± 0.8 5.6 ± 1.0 5.7 ± 0.8
RER 0.89 ± 0.08 0.86 ± 0.09 0.84 ± 0.09*
Values listed as mean ± SD. VE, ventilation; Bf, breathing frequency; 
VT, tidal volume; VO2, oxygen consumption; RER, respiratory 
exchange ratio. PLA, placebo; 1.5 and 3.0 represent dose of caffeine in 
mg·kg body weight-1. * Significantly different from placebo (p < 0.05).Journal of the International Society of Sports Nutrition 2007, 4:11 http://www.jissn.com/content/4/1/11
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significantly lower (p < 0.05) compared to both the
CAF1.5 and placebo trials at 45% of VO2max. RER with
CAF3 was significantly lower (p < 0.05) compared to the
CAF1.5 trial at 63% of VO2max. During maximal exercise
RER with CAF3 was significantly lower (p < 0.05) com-
pared to the placebo trial. There were no significant differ-
ences for VE, VO2, VT or RPE during the submaximal
workloads or at maximal exercise between trials. Bf was
significantly lower (p < 0.05) at 45% of VO2max with CAF3
vs placebo. However there were no significant differences
for Bf during any other submaximal workloads or at max-
imal exercise. There were also no differences between the
trials in the peak workload or in time to exhaustion at
their maximum workload.
Discussion
The results of this study provide evidence that caffeine at
low doses of 1.5 and 3.0 mg/kg body weight significantly
decreased heart rate during low to moderate intensity
cycle exercise in non-habitual caffeine users. These low
doses of caffeine did not significantly affect heart rate at
rest nor did they affect performance, HR, and BP at maxi-
mal exercise. Our results differ from other studies in that
systolic blood pressure was not higher in our subjects with
caffeine compared to control during exercise. At these
doses, caffeine had no effect on VE, VT, VO2, RPE, maximal
power output and time to exhaustion. Therefore those
young adult athletes that use heart rate monitors as an
indicator of their optimal pace should be aware of the
effect of caffeine lowering effect on heart rate during sub-
maximal exercise.
Investigating the cardiovascular effects of caffeine is not
new. In 1930, Grollman [29] had individual subjects
ingest various doses of caffeine and measured heart rate,
blood pressure, VO2 and cardiac output. Because caffeine
has been found to cause an increase in blood pressure, the
potential negative health consequences of caffeine con-
sumption are often a main focus of these studies. The
majority of studies that have investigated cardiovascular
effects of caffeine during exercise have used higher doses
(≥ 5 mg/kg body weight) and whether the studies utilized
habituated or non-habituated subjects has varied. To
examine the potential role that study design differences
(specifically dose, habituation status, and exercise inten-
sity) might contribute to the equivocal cardiovascular
effects of caffeine during exercise, we reviewed the litera-
ture for studies which reported the effects of caffeine on
heart rate and systolic blood pressure during exercise
(Table 3).
Comparing the results of the current study to previous
studies is somewhat difficult given the different doses of
caffeine, types and intensities of exercise, and the varied
use of either habituated or non-habituated subjects. How-
ever, our finding of a lower heart rate with caffeine use
during exercise is in agreement with three previous stud-
ies. Sullivan et al. [11] studied five habituated and five
non-habituated subjects who walked at 46% of VO2max
and observed that the five non-habituated subjects
showed a significantly lower heart rate after administra-
tion of 3.3 mg/kg caffeine (133.9 vs 143.7 during pla-
cebo) whereas the difference was not significant in the five
habituated subjects (121.8 vs 124.4). Gaesser and Rich
[10] gave 5 mg/kg caffeine to low to moderate caffeine
users and found lower heart rates (6–10 bpm) compared
to placebo at cycling exercise intensities between 30–70%
of VO2max. They found no difference in HR above 75% of
VO2max (HR > 160 bpm). More recently, Turley and Gerst
[12] found lower heart rates in young boys and girls dur-
ing cycle exercise at intensities of 41% and 64% of VO2max
(boys) and 51% and 77% of VO2max (girls) after a caffeine
dose of 5 mg/kg. Of note is that Sullivan et al. [11] used
3.3 mg/kg caffeine and the other two [10,12] used a
higher dose of caffeine (5 mg/kg). Further investigation
would seem warranted with different levels of caffeine
and comparing non-habituated vs. habitual caffeine users.
Our results are in contrast to a number of studies that have
reported no effect of caffeine administration on exercise
heart rate [13-28]. A possible explanation is that with one
exception [23] each of the remaining 15 studies used a ≥
Systolic blood pressure at rest and during exercise Figure 2
Systolic blood pressure at rest and during exercise. 
Differences in Systolic blood pressure between placebo and 
caffeine trials. Placebo, 1.5 and 3.0 represent dose of caffeine 
in mg·kg body weight-1. Values are listed as mean ± SE. * = 
the mean difference compared to placebo is significant (p < 
0.05)
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5 mg/kg dose of caffeine. Of note is that Perkins used
doses of 4, 7, and 10 mg/kg and found no heart rate dif-
ference between any of the trials compared to control for
exercise intensities at 50% of VO2max through maximal
exercise. The development of tolerance to the cardiovascu-
lar effects of caffeine in habitual users could also be a
potential confounder [1,2]. For example Robertson [30]
reported that three days of caffeine administration abol-
ished the pressor effect of caffeine in previously caffeine
naive subjects. From our review of the caffeine studies in
Table 3 the role of habituation is unclear: In the studies we
cited finding no change in heart rate during submaximal
exercise, five used habituated subjects [14,16,25-27] and
five used non-habituated subjects [16,18-21]. The remain-
ing studies did not report the habituation of their subjects
[13-15,23,24,28]. Furthermore Kaminsky [22] found no
change in heart rate during submaximal exercise between
their eight habituated vs eight non-habituated subjects
with administration of 5 mg/kg of caffeine.
Our results are also in direct contrast to several studies
which have found higher heart rates with caffeine during
exercise. McNaughton [7] observed higher heart rates dur-
ing cycling at workloads from 50 to 300 watts after high
doses (10 and 15 mg/kg) of caffeine compared with pla-
cebo. Sasaki [8] also found a significant increase in HR
with caffeine vs placebo but only during the last 30 min-
utes of a 2 hr running bout (intensity – 62–67% VO2max).
With a similar low dose of caffeine used in our study (3.3
mg/kg), Sung [9] found a higher heart rate response to a
67 watts workload in hypertensive but not normotensive
men. Finally, Bell [5,6] found that a dose of 5 mg/kg (in
both habitual and non-habitual users) resulted in a signif-
icant increase in HR at 80% and 85% VO2max but no effect
of caffeine on HR during cycling at a lower intensity (50%
of VO2max). Of note is that a separate previously men-
tioned study by Bell [14] found no difference in heart
rates at 80% of VO2max. Considering the possible factors
that might account for these findings not in agreement
with the present study, the intensity of exercise and the
higher dose of caffeine used may be the most likely. How-
ever differences in mode of exercise, duration, habituation
to caffeine, hypertension status, and perceived stress could
also be confounders.
Even though cardiac output was not measured in this
study, the similar levels in VO2 during each of the trials
would lead us to speculate that there was a comparable
cardiac output with the placebo and caffeine trials. Pin-
comb [31] at rest and both Engels [17] and Sullivan [11]
during exercise measured cardiac output and found no
difference on the caffeine compared to the placebo days.
Table 2: Respiratory and metabolic values during submaximal and maximal exercise
% of VO2max 30 45 63 Peak VO2
VE (L·min-1)
PLA 28.0 ± 2.3 41.5 ± 2.4 56.6 ± 3.4 129.0 ± 15.8
1.5 28.6 ± 3.0 42.7 ± 3.8 59.3 ± 5.3 129.1 ± 13.4
3.0 28.5 ± 2.4 42.0 ± 3.2 59.5 ± 6.0 127.1 ± 12.3
Bf (breaths·min-1)
PLA 19.3 ± 2.8 21.3 ± 2.8 23.5 ± 4.1 41.0 ± 8.3
1.5 18.7 ± 3.1 20.8 ± 3.2 23.2 ± 4.4 38.8 ± 6.0
3.0 18.0 ± 2.6 20.0 ± 3.3* 23.3 ± 4.1 38.9 ± 6.7
VT (L·breath-1)
PLA 1.55 ± 0.23 2.02 ± 0.27 2.50 ± 0.41 3.21 ± 0.36
1.5 1.63 ± 0.27 2.13 ± 0.28 2.64 ± 0.36 3.38 ± 0.31
3.0 1.67 ± 0.19 2.22 ± 0.42 2.63 ± 0.41 3.32 ± 0.36
VO2(ml·kg-1·min-1)
PLA 14.9 ± 1.6 22.6 ± 2.4 31.0 ± 3.3 49.7 ± 4.4
1.5 14.8 ± 0.9 22.7 ± 1.7 31.4 ± 2.7 50.7 ± 5.6
3.0 15.2 ± 1.0 23.0 ± 2.1 31.9 ± 3.2 50.3 ± 4.1
RER
PLA 0.85 ± 0.04 0.90 ± 0.02 0.94 ± 0.03 1.21 ± 0.05
1.5 0.86 ± 0.05 0.92 ± 0.03 0.96 ± 0.04 1.18 ± 0.06
3.0 0.82 ± 0.06 0.88 ± 0.05*† 0.93 ± 0.03† 1.16 ± 0.06*†
RPE
PLA 8.4 ± 1.3 11.7 ± 1.5 13.8 ± 0.9 19.0 ± 0.6
1.5 8.2 ± 1.3 11.0 ± 0.7 13.4 ± 1.0 19.1 ± 0.6
3.0 7.9 ± 1.1 11.3 ± 1.2 13.4 ± 1.0 19.3 ± 0.6
Values listed as mean ± SD. VE, ventilation; Bf, breathing frequency; VT, tidal volume; VO2, oxygen consumption; RER, respiratory exchange ratio; 
RPE, rating of perceived exertion. PLA, placebo; 1.5 and 3.0 represent dose of caffeine in mg·kg body weight-1.
* Significantly different from placebo (p < 0.05).
† Significantly different from 1.5 caffeine in mg·kg body weight-1. (p < 0.05).J
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) Table 3: Summary of previous studies of caffeine effects during submaximal exercise
Study Caffeine use Caffeine % of VO2max Mode Effects of caffeine on HR Systolic Blood Pressure
A Bangsbo (1992) n = 11 not reported 500 mg 80–100 Treadmill No diff Not studied
B Bell (1998) n = 8 habitual 5 mg/kg 85 Cycle ↑ at 5 min; not at 10 min Not studied
C Bell (2002) n = 8 non-habitual n = 13 habitual 5 mg/kg 50 & 80 Cycle No diff at 50%
↑ at 80% for both h + nh
Not studied
D Bell et al (2003) n = 9 habitual 5 mg/kg 80 Cycle No diff Not studied
E Casal et al (1985) n = 9 not reported 6 mg/kg 75 Treadmill No diff Not studied
F Daniels et al (1998) n = 10 non-habitual 6 mg/kg 65 Cycle No diff Higher with caffeine
G Engels et al (1999) n = 8 habitual 5 mg/kg 30 Cycle No diff Higher with caffeine
H Flinn et al (1990) n = 9 non-habitual 10 mg/kg 40–100 Cycle No diff Not studied
I French et al (1991) n = 6 non-habitual 10 mg/kg 75 Treadmill No diff Not studied
J Gaesser GA (1985) n = 8 habitual 5 mg/kg 37–100 Cycle ↓ at 37–77% max, no diff at max Not studied
K Graham et al (2000) n = 9 non-habitual 6 mg/kg 70 Cycle No diff Higher with caffeine
L Jacobsen et al (2001) n = 8 non-habitual 6 mg/kg 70 Cycle No diff Not studied
M Kaminsky (1998) n = 8 non-habitual n = 8 habitual 5 kg/mg 30, 50, 70 Treadmill No diff Higher for both groups with caffeine
N McNaughton (1987) n = 10 non-habitual 10 + 15 mg/kg Not reported Cycle ↑ Higher with caffeine Not studied
O Nishijima (2002) n = 8 habitual 300 mg 40–50 Cycle Not measured No diff
P Perkins R (1975) n = 14 not reported 4 + 7 + 10 mg/kg 50–100 Cycle No diff for any doses Not studied
Q Powers (1983) n = 7 not reported 5 mg/kg 25 – 100 Cycle No diff Not studied
R Sasaki (1987) n = 7 not reported 3.2 mg/kg 63 Treadmill ↑ Higher with caffeine Not studied
S Sullivan et al (1992) n = 5 non-habitual n = 5 habitual 3.3 mg/kg 45 Treadmill ↓ for non-habitual
No diff for habitual
Higher for both groups with caffeine
T Sung et al (1990) n = 34 habitual 5 mg/kg 25 & 50 Cycle No diff Higher with caffeine
U Sung et al (1995) n = 12 habitual 3.3 mg/kg Not reported Cycle No diff Higher with caffeine
V Tarnopolosky (1989) n = 6 habitual 6 mg/kg 70 Treadmill No diff Not studied
W Trice et al (1993) n = 8 habitual 5 mg/kg 85–90 Cycle No diff Not studied
X Turley & Gerst 
(2006)
n = 52 not reported 5 mg/kg 65% of max hr 
75% of max hr
Cycle ↓ for boys & girls at 65%
↓ for boys & girls at 75%
↑ for boys at 65%
↓ for girls at 75%
Y Weir et al (1987) n = 6 not reported 6.5 mg/kg 72–76 Treadmill No diff Not studied
McClaran (present study) n = 9 non-habitual 1.5 + 3 mg/kg 30, 46, 63 Cycle ↓ at 30-63% max No diff
All studies used adults as subjects except Turley & Gerst (2006)Journal of the International Society of Sports Nutrition 2007, 4:11 http://www.jissn.com/content/4/1/11
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Therefore we would further speculate that the lower heart
rate we observed during moderate exercise would indicate
an increased or optimized stroke volume. The most likely
mechanism would seem to be either an enhanced contrac-
tility or a higher preload with caffeine use during submax-
imal exercise in non-habituated subjects. Gould et al. [32]
showed an augmented (but not significant) stroke volume
with caffeine ingestion due to an enhanced left ventricular
end-diastolic volume. Robertson [33] speculates that caf-
feine's effect may be due to an enhancement of myocar-
dial contractility caused by methylxanthines.
Another possible explanation of a lowered HR is due to
the baroreflex reflexively lowering heart rate in response
to an elevation of BP in an attempt to reestablish "nor-
mal" BP [34]. Perhaps caffeine habituation might make
this reflex less sensitive and therefore result in no HR
change (and an increase in BP). In support of this, Sulli-
van [11] found HR decreases in non-habitual users but
not in habitual users, whereas the current study used non-
habitual users. While Turley and Gerst [12] did not report
caffeine use, because their subjects were children we
might assume that caffeine use was highly variable. How-
ever, Gaesser and Rich [10] used subjects who were low to
moderate caffeine users (100–200 mg/kg daily who
abstained from caffeine in the previous 24 hours) and
found a lower heart rate during exercise with caffeine.
Moreover, there has been previous mention of the studies
that used non-habituated caffeine users and showed sim-
ilar or higher heart rates after caffeine administration.
A final influence on the effect of caffeine on HR is the
effect that caffeine may have in the face of "stress". Coffee
has been shown to increase the HR response to mental
stress [35]. The tendency of caffeine alone to reduce heart
rate appears to be reversed when caffeine is consumed
during active coping stress. Rest and low to moderate
intensity exercise may be perceived as not very stressful,
especially in healthy and fit people. Our data indicated
that the effect of CAF on HR was not evident during higher
intensity exercise, perhaps because of the perception of
higher stress.
Lastly it is unclear as to why the lower heart rate during
submaximal exercise with the 1.5 and 3 mg/kg caffeine tri-
als disappears during near maximal and maximal exercise.
This similar heart rate response at high levels of exercise is
consistent with other studies using either habituated or
non-habituated subjects [10,13,14,18,23,24,27]. Based
on the previous discussion it could be that contractility or
preload cannot be further optimized at high exercise
intensity and therefore the caffeine effect is negated. Fur-
ther follow-up caffeine studies measuring stroke volume
would need to be conducted in order to fully illuminate
this question.
We observed that systolic blood pressure was significantly
higher at rest which is in agreement with most previous
studies [4,11,16,17,20,22,25]. In a review Myers [4] notes
that most of the recent studies at that time showed an
increase in blood pressure with caffeine at rest. He sug-
gested that the mechanisms of the higher blood pressure
response to caffeine could mostly be attributed to a pres-
sor effect caused by a sympathetic mediated vasoconstric-
tion. It has also been postulated that the higher systolic
blood pressure occurs because caffeine blocks the normal
vasodilatory effects of adenosine which can also lead to
peripheral vasoconstriction [11,17]. There remains more
to be done before caffeine's mechanism of action on
systolic BP is completely understood.
At the doses given in the current study caffeine had no
effect on systolic BP during exercise and this result differs
from previous studies showing increased systolic BP dur-
ing submaximal exercise intensity [1,11,16,17,22,25,36].
As discussed previously when comparing the heart rate
response, the difference in our findings could possibly be
explained by the mitigating effect of habitual caffeine use.
However it should be noted that the previous studies
using non-habituated subjects [11,16,22] show a signifi-
cantly higher systolic BP. Furthermore Kaminsky [22] and
Sullivan [11] who compared habituated to non-habitu-
ated subjects saw the same higher systolic BP response to
caffeine in both groups. The above studies used different
doses (between 3.3 mg/kg – similar to the present study
and 6 mg/kg) and consistently found a higher systolic BP
during submaximal exercise; therefore the amount of caf-
feine administered does not seem a likely explanation. A
closer analysis of our individual data revealed the follow-
ing: Of the nine subjects tested, four showed a consist-
ently higher systolic BP response with 3 mg/kg caffeine,
three were consistently lower and the last two had equiv-
ocal systolic BP data. Therefore there does not seem to be
an easy explanation as to why there is a discrepancy
between ours compared to other studies.
The timing of caffeine administration before the begin-
ning of exercise is yet another factor which may influence
cardiovascular effects. According to Graham [1] most
investigators have their participants take the caffeine dose
60 minutes prior to exercise. Looking at the studies in
Table 3 the range is anywhere from immediately before
exercise up to waiting three hours before exercise, with the
most common lag time from 40–60 minutes. Robertson
[33] showed however that the effect of caffeine (250 mg)
on resting heart rate was biphasic. An initial decrease
occurred between 45 and 75 minutes after administration,
followed by a mild increase above baseline levels begin-
ning at 105 minutes. Whether this effect would be altered
by caffeine dose or would persist during exercise is
unknown. However, the heart rates taken during our sub-Journal of the International Society of Sports Nutrition 2007, 4:11 http://www.jissn.com/content/4/1/11
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maximal exercise bouts occurred within the window
where caffeine elicited a drop in heart rate.
Conclusion
A review of lay press and scientific literature indicates a
frequently made statement that caffeine ingestion
increases heart rate. In an article for public education on
the MayoClinic.com website [37] entitled "Caffeine: Does
it help you lose weight?" a sentence reads: "Also, keep in
mind that caffeine is a stimulant that can increase your
heart rate ..." While technically accurate (contains the
word "can"), it does not indicate at what dose this might
likely be true. The association of caffeine and increased
HR is also often reported in the scientific exercise and
sports medicine literature. In a recent review article: "Caf-
feine as an Ergogenic Aid", Keisler and Armsey [3] state
"In the cardiovascular system, caffeine acts to increase
heart rate and blood pressure." Again, at what dose, and
whether the authors are speaking about resting or exercise
heart rate, is unclear from the text. In the discussion sec-
tion of their research study, Jacobson et al. [21] state,
"There is general agreement that caffeine ingestion
increases exercise heart rate because of its powerful effect
on the sympathetic nervous system." For this statement
the authors cite two references however, in neither cited
study were heart rates reported. These accounts are clearly
contradictory to the majority of the research literature and
perpetuation of the notion that caffeine increases heart
rate during exercise seems unwarranted. In addition we
noticed that most of the recent studies that compared
heart rates during exercise with caffeine administration
have typically cited only a few studies and have not con-
sidered the breadth of the possible issues. While not a
complete review of all the relevant studies we feel that the
studies we presented in Table 3 suggest there is more that
needs to be done before there is general agreement on the
caffeine effect on heart rate and blood pressure during
exercise.
Further investigations of the cardiovascular effects of caf-
feine are especially warranted with the recognition that its
performance enhancing effects on endurance exercise can
occur at doses near or below 3 mg/kg [1,38,39]. Already
the average American consumes 238 mg of caffeine per
day [1], however even more athletes may use these low
caffeine doses to obtain the ergogenic benefit. Our study
suggests in young, healthy subjects that a caffeine pill
comparable to 1–3 cups of coffee lowers heart rate during
submaximal exercise and therefore may alter workload
selection when using a heart rate monitor as an index for
exercise intensity. Clearly, clarification of caffeine's cardi-
ovascular effects at these low but effective doses is impor-
tant. In addition, the cardiovascular effects of caffeine
with different exercise intensities, mode, sex, age and fit-
ness as well as the mechanism(s) responsible for cardio-
vascular effects remains to be clarified. In addition further
research could be completed that specifically determines
if there are differences between habituated vs. non-habit-
uated users and also that compares the effect of various
other caffeine doses (e.g., 4, 5 & 6 mg/kg caffeine).
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